Health Care • Hospital/Nursing Management
$180.65 ▲ +4.60
(+2.61%)
MKT CAP: $10.38B • VOL: 911.0K
52W L $140 52W H $246
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$152
MEDIAN
$202
MEAN
$206
HIGH
$246
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE UHS TAPE
UHS // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $218.59 | $207.75 | 2025-02-14 | $164.39 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $227.62 | $213.17 | 2025-02-06 | $169.81 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $205.94 | $198.72 | 2025-01-29 | $173.42 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $184.26 | — | 2025-01-17 | $177.04 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $158.97 | $171.62 | 2025-01-09 | $160.78 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $214.97 | $187.88 | 2024-12-18 | $157.17 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $175.23 | $182.46 | 2024-12-04 | $168.00 | -4.3% | 48% | C |